Moedas / CRVS
CRVS: Corvus Pharmaceuticals Inc
5.74
USD
0.33
(6.10%)
A taxa do CRVS para hoje mudou para 6.10%. Paralelamente, o preço mais baixo no mercado atingiu 5.34 e o mais alto foi 5.75.
Veja a dinâmica do par de moedas Corvus Pharmaceuticals Inc. As cotações em tempo real ajudam a reagir rapidamente aos movimentos do mercado. Ao alternar entre os diferentes períodos de tempo, você pode monitorar tendências e movimentos de preços por minuto, hora, dia, semana ou mês. Use estas informações para prever os movimentos do mercado e tomar decisões de negociação informadas.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
CRVS Notícias
- Core Scientific stock price target raised to $22 by Jefferies on acquisition outlook
- Corvus Stock: Positive Phase 1 Soquelitiinb Trial Data Brings 2025 Catalysts (NASDAQ:CRVS)
- Corvus Q1 2025 presentation: Phase 1 atopic dermatitis data drives stock surge
- Tuesday’s Insider Activity: Major Buys and Sells Shake Up Markets
- OrbiMed Advisors sells Corvus Pharma (CRVS) shares worth $4.89 million
- China approves Corvus partner’s IND for atopic dermatitis drug trial
- Corvus stock maintains Outperform rating at Mizuho amid positive sector data
- Corvus Pharmaceuticals: Multiple Opportunities, But Plenty Of Risk
- Corvus stock rating reiterated by Cantor Fitzgerald on atopic dermatitis drug
- Corvus Pharmaceuticals Presents Soquelitinib Preclinical Data Highlighting Potential of ITK inhibition to Treat Systemic Sclerosis at EULAR 2025 Congress
- Corvus reports promising interim data on atopic dermatitis drug
- Corvus Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference
- Mizuho cuts Corvus Pharmaceuticals target to $11, keeps rating
- Why Is Corvus Pharmaceuticals Stock Soaring On Friday? - Corvus Pharma (NASDAQ:CRVS)
- Corvus Pharmaceuticals shares surge on positive trial results
- Why Pinterest Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket - Corvus Pharma (NASDAQ:CRVS), Clean Energy Technologies (NASDAQ:CETY)
- Corvus Pharmaceuticals' Short Runway Overshadows Soquelitinib's Promising Trials
- Corvus Pharmaceuticals Stock: Now At Cruising Altitude (NASDAQ:CRVS)
- Corvus Pharmaceuticals, Inc. (CRVS) Q4 2024 Earnings Call Transcript
- Corvus Pharmaceuticals: Small Market, Many Competitors, Low Cash Balance (NASDAQ:CRVS)
Faixa diária
5.34
5.75
Faixa anual
2.54
10.01
- Fechamento anterior
- 5.41
- Open
- 5.42
- Bid
- 5.74
- Ask
- 6.04
- Low
- 5.34
- High
- 5.75
- Volume
- 1.039 K
- Mudança diária
- 6.10%
- Mudança mensal
- 40.00%
- Mudança de 6 meses
- 38.65%
- Mudança anual
- 29.28%
31 agosto, domingo